Pharmacokinetic, Safety and Tolerability Study of SC Administered Bisphosphonate With rHuPH20 vs Bisphosphonate Alone
Clinical trial NCT00807963 · COMPLETED
Trial details
- NCT number
- NCT00807963
- Sponsor
- Halozyme Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2009-09-21
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.